Skip to main content
logo
COSCIENS Biopharma Inc. (CSCI)
NASDAQ: CSCI · Real-Time Price · USD
2.450
-0.270 (-9.93%)
At close: Sep 4, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202013 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2013 - 2019
Active Ingredient
11.63M
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical
1.50M
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical Growth
-75.29%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202013 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2013 - 2019
United States
9.17M
Log In
Log In
Log In
Log In
Upgrade
Germany
1.86M
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
1.34M
Log In
Log In
Log In
Log In
Upgrade
Colombia
410.99K
Log In
Log In
Log In
Log In
Upgrade
Other
356.19K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
449.80%
Log In
Log In
Log In
Log In
Upgrade
Switzerland
-
Log In
Log In
Log In
Log In
Upgrade
Switzerland Growth
-
Log In
Log In
Log In
Log In
Upgrade
Ireland
-
Log In
Log In
Log In
Log In
Upgrade
Ireland Growth
-
Log In
Log In
Log In
Log In
Upgrade
Denmark
-
Log In
Log In
Log In
Log In
Upgrade
Denmark Growth
-
Log In
Log In
Log In
Log In
Upgrade